Exact Mass: 536.3614

Exact Mass Matches: 536.3614

Found 61 metabolites which its exact mass value is equals to given mass value 536.3614, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cyclopassifloic acid A

4,6-dihydroxy-7,12,16-trimethyl-15-[3,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


Cyclopassifloic acid A is found in fruits. Cyclopassifloic acid A is a constituent of Passiflora edulis (passion fruit) Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid A is found in fruits.

   

Cyclopassifloic acid C

4,6-dihydroxy-7,12,16-trimethyl-15-[2,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


Cyclopassifloic acid C is found in fruits. Cyclopassifloic acid C is a constituent of Passiflora edulis (passion fruit)

   

Cyclotricuspidogenin C

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


Cyclotricuspidogenin B is found in fruits. Cyclotricuspidogenin B is isolated from Passiflora edulis (passion fruit).

   

DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C31H52O7 (536.3713)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5S,6Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5S,6Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C31H52O7 (536.3713)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C31H52O7 (536.3713)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C31H52O7 (536.3713)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C31H52O7 (536.3713)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C31H52O7 (536.3713)


DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C31H52O7 (536.3713)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Cyclopassifloic acid F

(+)-Cyclopassifloic acid F

C31H52O7 (536.3713)


   

Cyclopassifloic acid G

(+)-Cyclopassifloic acid G

C31H52O7 (536.3713)


   

SCHEMBL9578041

SCHEMBL9578041

C27H52O10 (536.356)


   

Lsccijalaric ester II

Lsccijalaric ester II

C31H52O7 (536.3713)


   

iriomotelide-5a

iriomotelide-5a

C31H52O7 (536.3713)


   

N-3-Benzoyl-cycloxobuxidin-F

N-3-Benzoyl-cycloxobuxidin-F

C33H48N2O4 (536.3614)


   

Cyclotricuspidogenin C

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

Cyclopassifloic acid A

4,6-dihydroxy-7,12,16-trimethyl-15-[3,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

Cyclopassifloic acid C

4,6-dihydroxy-7,12,16-trimethyl-15-[2,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

N-stearoyl-O-phosphocholineserine

N-octadecanoyl-O-phosphocholine-L-serine

C26H53N2O7P (536.359)


   

Lobophysterol B

20R-hydroperoxy,11alpha-acetoxy-23R-methyl-ergosta-16-en-3beta,5alpha,6beta-triol

C31H52O7 (536.3713)


   

Michosterol A

20S-hydroperoxy-25-acetoxy-23R-methyl-ergost-16-en-3beta,5beta,6alpha-triol

C31H52O7 (536.3713)


   

Michosterol B

Michosterol B

C31H52O7 (536.3713)


   

Boc-His(Boc)-OH DCHA

Boc-His(Boc)-OH DCHA

C28H48N4O6 (536.3574)


   

DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C31H52O7 (536.3713)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0)

C31H52O7 (536.3713)


   

DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C31H52O7 (536.3713)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0)

C31H52O7 (536.3713)


   

DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C31H52O7 (536.3713)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0)

C31H52O7 (536.3713)


   

DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C31H52O7 (536.3713)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0)

C31H52O7 (536.3713)


   

DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C31H52O7 (536.3713)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0)

C31H52O7 (536.3713)


   

DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C31H52O7 (536.3713)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0)

C31H52O7 (536.3713)


   

17,24-epoxy-25-hydroxy-21-methoxy-3,4-secobaccharane

17,24-epoxy-25-hydroxy-21-methoxy-3,4-secobaccharane

C31H52O7 (536.3713)


A natural product found in Aglaia foveolata.

   

PE-Cer 12:0;2O/12:1;O

PE-Cer 12:0;2O/12:1;O

C26H53N2O7P (536.359)


   

PE-Cer 12:1;2O/12:0;O

PE-Cer 12:1;2O/12:0;O

C26H53N2O7P (536.359)


   

[3-[2,3-bis[[(4E,7E)-deca-4,7-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

[3-[2,3-bis[[(4E,7E)-deca-4,7-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium

C30H50NO7+ (536.3587)


   

[3-[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

[3-[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C30H50NO7+ (536.3587)


   

[3-[3-acetyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

[3-[3-acetyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C30H50NO7+ (536.3587)


   

2-[carboxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C30H50NO7+ (536.3587)


   

CerPE 14:1;O2/10:0;O

CerPE 14:1;O2/10:0;O

C26H53N2O7P (536.359)


   

CerPE 24:1;O2;O

CerPE 24:1;O2;O

C26H53N2O7P (536.359)


   

ST 25:0;O;GlcA

ST 25:0;O;GlcA

C31H52O7 (536.3713)


   

ST 25:1;O2;Hex

ST 25:1;O2;Hex

C31H52O7 (536.3713)


   

(1s,3s,4s,6s,7s,8r,11s,12s,14r,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,14r,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}benzenecarboximidic acid

n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}benzenecarboximidic acid

C33H48N2O4 (536.3614)


   

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-4,6-dihydroxy-7,12,16-trimethyl-15-[(2s,3r,5s)-3,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-4,6-dihydroxy-7,12,16-trimethyl-15-[(2s,3r,5s)-3,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

n-[(1r,3r,6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1r)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

n-[(1r,3r,6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1r)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

C33H48N2O4 (536.3614)


   

(2e)-3-[(1s,2r,4as,5r,8s,8ar)-5-hydroxy-4a,8-dimethyl-2-[(2e,5s,7r,9r,10s,11s)-5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

(2e)-3-[(1s,2r,4as,5r,8s,8ar)-5-hydroxy-4a,8-dimethyl-2-[(2e,5s,7r,9r,10s,11s)-5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

C31H52O7 (536.3713)


   

3-[5-hydroxy-4a,8-dimethyl-2-(5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

3-[5-hydroxy-4a,8-dimethyl-2-(5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

C31H52O7 (536.3713)


   

(1s,3s,4s,6s,7s,8r,11s,12s,14s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,14s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)


   

(1s,3s,4s,6s,7s,8r,11s,12s,15s,16r)-4,6-dihydroxy-7,12,16-trimethyl-15-[(2s,5s)-2,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,15s,16r)-4,6-dihydroxy-7,12,16-trimethyl-15-[(2s,5s)-2,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O7 (536.3713)